Business Insider1mon
Globus Medical price target raised to $90 from $85 at Truist
Truist raised the firm’s price target on Globus Medical (GMED) to $90 from $85 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 in Medical Technology.
Nasdaq1mon
Treace Medical price target raised to $8.40 from $7 at Truist
Truist raised the firm’s price target on Treace Medical (TMCI) to $8.40 from $7 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 in Medical Technology.
American Banker22d
Truist's COO, who oversaw strategy revamp, resigns
Truist Financial on Monday said its chief operating officer has resigned and won't be replaced, the latest step to simplify the company's operations amid its yearslong strategy overhaul. Hugh S. "Beau ...
ETF Daily News1mon
Truist Financial Cuts Pediatrix Medical Group (NYSE:MD) Price Target to $15.00
Pediatrix Medical Group (NYSE:MD – Get Free Report) had its price target dropped by equities researchers at Truist Financial from $16.00 to $15.00 in a report released on Monday,Benzinga reports.